Advertisement

After the ED: Arranging Post-ED Follow-up Care

Chapter
  • 535 Downloads

Key Chapter Points

Patients treated in the ED for acute headache have a high rate of return visits. The reasons for the high rate of return visits may include recurrence of severe headache pain, lack of an effective interim treatment plan and medications, and an inability to be seen by a headache-interested provider in a timely manner. Return visits can be reduced by effectively treating headache pain and nausea in the ED, providing the patient with a clear, written interim treatment strategy, providing prescriptions for effective medications that can be used in the interim, and facilitating timely follow up with a headache-interested provider.

Keywords

Follow up Recurrence Return visit 

References

  1. 1.
    Gupta MX, Silberstein SD, Young WB, et al. Less is not more: underutilization of headache medications in a university hospital emergency department. Headache. 2007;47:1125–33.PubMedCrossRefGoogle Scholar
  2. 2.
    Friedman BW, Hochberg ML, Esses D, et al. Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomes. Ann Emerg Med. 2008;52:696–704.PubMedCrossRefGoogle Scholar
  3. 3.
    Friedman BW, Solorzano C, Xia S, et al. Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan. Ann Emerg Med. 2010;56:7–17.PubMedCrossRefGoogle Scholar
  4. 4.
    Martins IP, Gouveia RG. More on water and migraine. Cephalalgia. 2007;27:372–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Spigt MG, Kuijper EC, van Schayck CP, et al. Increasing the daily water intake for the prophylactic treatment of headache: a pilot trial. Eur J Neurol. 2005;12:715–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Villiani V, Di Stani F, Vanacore N, et al. The “repeater” phenomenon in migraine patients: a clinical and psychometric study. Headache. 2010;50:348–56.CrossRefGoogle Scholar
  7. 7.
    Wilper A, Woolhandler S, Himmelstein D, Nardin R. Impact of insurance status on migraine care in the United States: a population-based study. Neurology. 2010;74:1178–83.PubMedCrossRefGoogle Scholar
  8. 8.
    Spitzer RL, Kroenke K, Williams JW, Löwe B. A brief measure for assessing generalized ­anxiety disorder. The GAD-7. Arch Intern Med. 2006;166:1092–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Parker G, Hilton T, Bains J, Hadzi-Pavlovic D. Cognitive-based measures screening for depression in the medically ill: the DMI-10 and the DMI-18. Acta Psychiatr Scand. 2002;105:419–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of AnesthesiologyUniversity of PittsburghPittsburghUSA
  2. 2.Dean Health SystemsMadisonUSA

Personalised recommendations